Zusammenfassung
In diesem Kapitel werden prinzipielle peptiderge Mechanismen und die folgenden Neuropeptide im Detail besprochen: Tachykinine, opioide Peptide, Somatostatine, Oxytocin und Vasopressin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Weiterführende Literatur
Brain SD, Cox HM (2006) Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br J Pharmacol 147 Suppl 1: S202–211
Corbett AD, Henderson G, McKnight AT, Paterson SJ (2006) 75 years of opioid research: the exciting but vain quest for the Holy Grail. Br J Pharmacol 147 Suppl 1: S153–162
Hökfelt T, Bartfai T, Bloom F (2003) Neuropeptides: opportunities for drug discovery. Lancet Neurol 2(8): 463–472
Pasternak GW, Pan YX (2013) Mu opioids and their receptors: evolution of a concept. Pharmacol Rev 65(4): 1257–1317
Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V (2002) The tachykinin peptide family. Pharmacol Rev 54(2): 285–322
Stoop R (2012) Neuromodulation by oxytocin and vasopressin. Neuron 76(1): 142–159
Viollet C, Lepousez G, Loudes C, Videau C, Simon A, Epelbaum J (2008) Somatostatinergic systems in brain: networks and functions. Mol Cell Endocrinol 286(1–2): 75–87
Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C (2003) Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov 2(12): 999–1017
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Böhm, S. (2016). Peptiderge Systeme. In: Pharmakologie und Toxikologie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46689-6_21
Download citation
DOI: https://doi.org/10.1007/978-3-662-46689-6_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-46688-9
Online ISBN: 978-3-662-46689-6
eBook Packages: Medicine (German Language)